Molecular Characterisation of Appendiceal Cancer

Recruiting now

Conditions studied: Appendiceal Cancer

In brief

Patients ≥ 18 years old who have been diagnosed with appendiceal cancer with peritoneal metastases, have had cytoreductive surgery, have availability of archival tumour tissue and have consented to our institutional biobank program or have a waiver of consent for deceased patients who have not had the opportunity to provide biobank consent (requested at the time of ethics review). Descriptive analysis of the proportion of genetic mutations identified in appendiceal cancers. This is given by the percentage of pathogenic mutations in the peritoneal metastasis compared to the primary tumour.

Key facts

Study ID

NCT05364788

Run by

The Christie NHS Foundation Trust

People needed

100

Starts

2024-02-04

Expected to finish

2025-07-03

Last updated by the study team

2025-01-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants are eligible to be included in the study only if all of the following criteria apply:
• Patients ≥ 18 years old who have been diagnosed with appendiceal cancer with peritoneal metastases,
• have had cytoreductive surgery
• have availability of archival tumour tissue

You may not qualify if…

• None

Where it is running

• The Christie NHS Foundation Trust — Manchester, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.